1 option
Critical care and COVID-19 / edited by Salim Surani, Syed Anjum Khan, Reena Shah.
- Format:
- Book
- Series:
- Infectious Diseases and Microbiology Series
- Language:
- English
- Subjects (All):
- COVID-19 (Disease).
- COVID-19 (Disease)--Pathophysiology.
- COVID-19 (Disease)--Treatment.
- Physical Description:
- 1 online resource (420 pages)
- Edition:
- 1st ed.
- Place of Publication:
- New York : Nova Science Publishers, Inc., [2023]
- Summary:
- "Since its emergence in late 2019, COVID-19 has sparked global catastrophe, taking the lives of millions around the world. This pandemic has deeply challenged the global community across sectors, including health and economics. Constantly evolving information led to millions of publications related to the disease in less than two years, a ground-breaking magnitude in the world of academic. This book "Critical Care & COVID-19" summarizes what we know about COVID-19 as it pertains to epidemiology, pathology, therapeutics, and effects on different organ systems. It also dives into the mental health challenges as a result of COVID-19, the nursing and respiratory therapist journey, and lessons learned from the frontline. This 25-chapter book covers the COVID-19 spectrum and benefits clinicians, nurses, respiratory therapists, pharmacists, and regulators"-- Provided by publisher.
- Contents:
- Intro
- Contents
- Preface
- Chapter 1
- COVID-19: Virology, Pathogenesis, and Pathophysiology
- Abstract
- Introduction
- Virology
- Variants
- Pathogenesis
- Transmission
- Risk Factors
- Conclusion
- References
- Chapter 2
- COVID-19: Clinical Presentations in Adults
- Clinical Presentation
- Incubation Period
- Clinical Manifestation
- Pulmonary and Extrapulmonary Manifestations of COVID-19
- Chapter 3
- The Role of Diagnostic Imaging in the Management of COVID-19 Patients
- Chest X-Rays
- Computed Tomography
- Ultrasonography
- Positron Emission Tomography
- Chapter 4
- Predictors of Severity and Complications in Patients with COVID-19
- Abbreviations
- Methods
- COVID-19 Symptoms
- Clinical Predictors of Disease Severity
- Patient Demographics
- Age
- Sex and Ethnicity
- Unvaccinated Status
- Comorbid Diseases
- Clinical Features
- Hypoxia
- Radiographic Predictors
- Laboratory Test Predictors
- Inflammatory Markers
- Coagulation Tests
- Markers of End Organ Damage
- Cardiac Dysfunction
- Kidney Injury
- Liver Injury
- Viral Factors
- Nonspecific Biomarkers of Cell Injury
- Risk Score Calculators
- Hospital Level Variation
- Predictors of Disease Severity in Pediatric Patients
- Chapter 5
- Treatment: Pharmacotherapy for COVID-19 in the ICU
- Antivirals
- Remdesivir
- Timing of Therapy Initiation
- Expected Efficacy of Treatments
- Dosing and Monitoring Parameters
- Adverse Effects
- Corticosteroids
- Methylprednisolone
- Hydrocortisone
- Dexamethasone
- Immunomodulators: Interleukin-6 Inhibitors.
- Tocilizumab
- Sarilumab
- Expected Efficacy of Treatment
- Immunomodulators: Interleukin-1 Inhibitors
- Anakinra
- Immunomodulators: Janus Kinase Inhibitors
- Baricitinib
- Tofacitinib
- Expected Efficacy
- Convalescent Plasma
- Monoclonal Antibodies
- Guideline Recommendations
- Chapter 6
- The Respiratory Management of COVID-19 in Hospitalized Patients
- Infectivity and Transmission Characteristics
- Transmission from Animals to Humans
- Transmission from Human to Human
- Infectivity
- Outcome
- Use of Respiratory Assist Device
- Supplemental Oxygen
- High-Flow Nasal Cannula and NIV
- Proning
- ECMO
- Nebulization
- Bronchoscopy
- Chapter 7
- The Physiology of Proning and PEEP in ARDS Patients Due to COVID-19
- Definition and Types
- Prone Positioning
- Positive End-Expiratory Pressure Ventilation
- Pathophysiology/Respiratory Mechanics
- Mechanical Forces Due to the Gravitational Vector
- Intra Compartmental Pressures (Intra-Abdominal and Intra-Thoracic Pressures)
- Chest Wall Mechanics, Lung Volumes and Elastance
- Alveolar Recruitment
- Ventilation-Perfusion Ratio
- Indications, Timing, and Techniques in COVID-19 ARDS
- PEEP
- Contraindications
- Advantages
- Complications
- PEEP.
- Considerations/Limitations for Use
- Prone Ventilation
- Chapter 8
- Cardiovascular Complications in COVID-19
- Myocardial Injury
- Myocarditis
- Stress Cardiomyopathy
- ST-Elevation Myocardial Infarction (STEMI)
- Heart Failure (HF)
- Cardiac Arrhythmia
- QTc Prolongation
- Atrial Fibrillation (AF)
- Cardiac Arrest
- Ventricular Arrhythmia
- Bradyarrhythmia
- Chapter 9
- Gastrointestinal Manifestations in COVID-19
- Discussion
- Histopathology
- Inflammatory Bowel Disease
- Liver Enzyme Abnormalities
- Chapter 10
- Hematological Abnormalities in COVID-19 Patients
- Pathogenesis of COVID-19
- COVID-19-Associated Coagulopathy
- Hypercoagulable State
- Endothelial Injury
- Stasis
- Pathogenesis of CAC
- Anticoagulation
- Anticoagulation Dosing for Patients in the Absence of Confirmed or Suspected VTE
- Anticoagulation Dosing for ICU Level of Care
- Hospitalized Patients Not Requiring ICU Level Care
- Ambulatory or Patients Discharged from the Hospital
- Prophylactic and Treatment Regimens
- Other Hematological Abnormalities
- Anemia
- Lymphopenia
- Neutrophilia
- Management of These Abnormalities
- COVID-19 and Autoimmune Hematologic Disorders
- Immune Thrombocytopenic Purpura (ITP)
- Autoimmune Hemolytic Anemia (AIHA)
- Chapter 11
- Musculoskeletal and Rheumatologic Manifestations in COVID-19
- Musculoskeletal: Acute Phase Symptoms
- Autoantibodies in Patients with COVID-19
- Outcomes in Patients with Preexisting Rheumatological Disease
- Long Term COVID
- Avascular Bone Necrosis
- Chapter 12
- Neurological Manifestations in COVID-19
- Abstract.
- Introduction
- Central Nervous System
- Altered Taste and Smell
- Encephalopathy and Encephalitis
- Headache
- Cerebrovascular Disease
- Neuro-Inflammation
- Long COVID
- Peripheral Nervous System
- Acute Polyneuropathy
- Neuromuscular
- Chapter 13
- Multisystem Inflammatory Syndrome (MIS) in COVID-19
- Fever
- Dermatologic/Mucocutaneous
- Gastrointestinal
- Cardiovascular
- Hematologic
- Neurologic
- Respiratory
- Pathophysiology
- Diagnosis
- MIS-A
- MIS-C
- Differential Diagnosis
- After COVID-19 Vaccine
- Prognosis
- Management
- Multisystem Inflammatory Syndrome in Children (MIS-C)
- Multisystem Inflammatory Syndrome in Adults (MIS-A)
- Multisystem Inflammatory Syndrome after COVID-19 Vaccine (MIS-V)
- Pharmacology
- Vasopressor (Epinephrine or Norepinephrine)
- Empiric Antibiotics
- Chapter 14
- Mediastinal Adenopathy in COVID-19: Lumpy Bumpy Mediastinal Lymph Node in COVID-19: What to Do?
- Mediastinal Lymphadenopathy
- Chest Imaging in COVID-19
- Mediastinal Lymphadenopathy in COVID-19
- Diagnosis, Management, and Prognosis of Mediastinal Lymphadenopathy
- Chapter 15
- Barotrauma in COVID-19
- Pathophysiology of Barotrauma in COVID-19
- Incidence of Barotrauma in COVID-19 Patients
- Barotrauma in the General Hospitalized COVID-19 Patient Population
- Barotrauma in the General ICU Patient Population
- Barotrauma in the Mechanically Ventilated COVID-19 ICU Patient Population
- Barotrauma in the COVID-19 ICU Patient Population with ARDS (Acute Respiratory Distress Syndrome)
- Incidence of the Subtypes of Barotrauma
- Pneumothorax
- Pneumomediastinum.
- Subcutaneous Emphysema
- Pneumopericardium
- Chapter 16
- Long COVID Syndrome
- Terminology and Definition
- Prevalence
- Why Do Estimates of Prevalence Vary?
- How Does Prevalence Vary across Different Populations?
- Sex
- Race and Ethnicity
- Sexual Orientation
- Comorbidities
- The Severity of Initial Infection
- Vaccination
- Variants of COVID-19
- Risk Factors for the Development of Long COVID
- Symptoms and Complications
- General
- Respiratory (Bull-Otterson et al., 2022
- Carvalho-Schneider et al., 2021
- Malahfji et al., 2022
- Xie et al., 2022)
- Cardiovascular (Xie et al., 2022)
- Neurological
- Mental Health
- Immune System
- Musculoskeletal
- Renal (Bowe et al., 2021)
- Endocrine (Bansal et al., 2022
- Xie &
- Al-Aly, 2022)
- Gastrointestinal Issues
- Dermatologic
- Symptoms Related to the Stress of Illness
- Diagnostic Workup
- Prognostic Factors
- Treatment
- Post-COVID Clinics
- Targeted Therapies
- Future
- Psychosocial Impact (L. Huang et al., 2022
- Ziauddeen et al., 2022)
- Chapter 17
- The Role of Extracorporeal Membrane Oxygenation in COVID-19
- Mechanism of Action and Historical Aspects
- Impact of ECMO in Previous Respiratory Pandemics
- Severe Acute Respiratory Syndrome (SARS) - 2003
- Middle East Respiratory Syndrome (MERS) - 2012
- Pandemic H1N1 Influenza - 2009
- Characteristics of Critically Ill Patients with COVID-19
- The Respiratory System
- The Cardiovascular System
- The Hematologic and Immune System
- Other Systems
- Summary of Current Medical Literature Evaluating ECMO Application in COVID-19
- Randomized Controlled Trials (RCTs)
- Systematic Reviews and Meta-Analyses.
- Types of ECMO and Their Utility in COVID-19.
- Notes:
- Description based on print version record.
- Includes bibliographical references and index.
- Other Format:
- Print version: Surani, Salim Critical Care and COVID-19
- ISBN:
- 979-88-86979-69-5
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.